Is It Time to Consider Germline Testing for All Lung Cancer Patients?

In a large study, 15% of patients with lung cancer had pathogenic germline variants, and most of these variants were deemed clinically actionable.

Related Keywords

Virginia ,United States ,Richmond ,Renato Martins ,Massey Cancer Center ,National Comprehensive Cancer Network ,Cancer Center ,Pacific Islander ,